Overview

  • Product nameAnti-NAPRT1 antibody
    See all NAPRT1 primary antibodies
  • Description
    Rabbit polyclonal to NAPRT1
  • Tested applicationsSuitable for: IHC-Fr, WBmore details
  • Species reactivity
    Reacts with: Human
  • Immunogen

    Synthetic peptide derived from the C-terminal domain of human NAPRT1.

Properties

Applications

Our Abpromise guarantee covers the use of ab71566 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application Abreviews Notes
IHC-Fr Use at an assay dependent concentration.
WB 1/200 - 1/2000. Predicted molecular weight: 57 kDa.

Target

  • FunctionCatalyzes the conversion of nicotinic acid (NA) to NA mononucleotide (NaMN). Essential for NA to increase cellular NAD levels and prevent oxidative stress of the cells.
  • PathwayCofactor biosynthesis; NAD(+) biosynthesis; nicotinate D-ribonucleotide from nicotinate: step 1/1.
  • Sequence similaritiesBelongs to the NAPRTase family.
  • Cellular localizationCytoplasm > cytosol.
  • Information by UniProt
  • Database links
  • Alternative names
    • FHA HIT interacting protein antibody
    • FHA-HIT-interacting protein antibody
    • FHIP antibody
    • NAPRT1 antibody
    • NAPRTase antibody
    • Nicotinate phosphoribosyltransferase antibody
    • Nicotinate phosphoribosyltransferase domain containing 1 antibody
    • Nicotinate phosphoribosyltransferase domain-containing protein 1 antibody
    • Nicotinic acid phosphoribosyltransferase antibody
    • PNCB_HUMAN antibody
    • PP3856 antibody
    see all

References for Anti-NAPRT1 antibody (ab71566)

ab71566 has not yet been referenced specifically in any publications.

Product Wall

There are currently no Abreviews or Questions for ab71566.
Please use the links above to contact us or submit feedback about this product.

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"